ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Ann Thorac Surg 2009;88:e9-e10. doi:10.1016/j.athoracsur.2009.05.018
© 2009 The Society of Thoracic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Alfredo Cesario
Giacomo Cusumano
Stefano Margaritora
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lococo, F.
Right arrow Articles by Margaritora, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lococo, F.
Right arrow Articles by Margaritora, S.
Related Collections
Right arrow Lung - other

Case Reports

Pulmonary Metastases From Parachordoma

Filippo Lococo, MDa,*, Alfredo Cesario, MDa,b, Elisa Meacci, MDa, Giacomo Cusumano, MDa, Stefano Margaritora, MDa

a Department of Thoracic Surgery, Catholic University and Scientific Direction, Rome, Italy
b CdC San Raffaele Velletri and IRCCS San Raffaele Pisana, Rome, Italy

Accepted for publication May 4, 2009.

* Address correspondence to Dr Lococo, Department of Thoracic Surgery, Catholic University, Largo F. Vito n 1, Rome, 00168, Italy (Email: filippo_lococo{at}yahoo.it).

A young woman was referred to our institution for the appearance of a single pulmonary nodule at a routine follow-up computed tomographic scan of the thorax. She had been operated on 4 years earlier for a parachordoma of the iliopsoas muscle. Wedge resections were accessed through a mini-thoracotomy, and the pathologic examination confirmed the diagnosis of parachordoma lung metastases. Adjuvant chemotherapy (Glivec, 400 mg/daily [imatinib; Novartis, Basel, Switzerland]) was indicated and was administered for 10 months. At the time this case report was written, the patient was alive with no sign of tumor recurrence. We believe that metastatic parachordoma to the lung has been previously reported only once in the English literature. Our case adds evidence that parachordoma, despite its generally indolent behavior, can metastasize to the lung.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The Society of Thoracic Surgeons.